Comparison

WRW4 (TFA) European Partner

Item no. HY-P1119A-1ea
Manufacturer MedChem Express
Amount 1 ea
Quantity options 100 mg 1 ea
Category
Type Molecules
Specific against other
Formula C63H66F3N15O8
Citations [1]Bae YS, et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol. 2004;173(1):607-614.
Smiles O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC3=CNC4=CC=CC=C34)C(N[C@@H](CC5=CNC6=CC=CC=C56)C(N[C@@H](CC7=CNC8=CC=CC=C78)C(N)=O)=O)=O)=O)=O)[C@H](CC9=CNC%10=CC=CC=C9%10)N.OC(C(F)(F)F)=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping condition Room temperature
Available
Manufacturer - Type
Peptides
Manufacturer - Applications
Neuroscience-Neuromodulation
Manufacturer - Targets
Formyl Peptide Receptor (FPR)
Shipping Temperature
Room Temperature
Molecular Weight
1218.29
Product Description
WRW4 TFA, a specific formyl peptide receptor-like 1 (FPRL1) antagonist, inhibits WKYMVm binding to FPRL1 with an IC50 of 0.23 μM. WRW4 TFA specifically inhibits the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid beta42 (Abeta42) peptide, and F peptide[1].
Manufacturer - Research Area
Neurological Disease
Solubility
10 mM in DMSO
Manufacturer - Pathway
GPCR/G Protein
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close